Clinical Trials Browser

Phase NA × Myelodysplastic Syndromes × Rituximab × Clear all

NCT00648037 2016-02-01

Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT

Phase NA Completed

26 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes